SEM Stock News & Analysis | Latest Updates

SELECT MEDICAL HOLDINGS CORPORATION APPOINTS THOMAS P. MULLIN AS CHIEF EXECUTIVE OFFICER AND ANNOUNCES OTHER CHANGES INVOLVING LONG-TENURED LEADERS

(NYSE:SEM) MECHANICSBURG, Pa., Sept. 2, 2025 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE: SEM) today announced the appointment of Thomas P. Mullin as its chief executive officer. David S. Chernow, who has held the position since 2014, has been appointed vice chairman...

September 2, 2025Management

SEM News

SELECT MEDICAL HOLDINGS CORPORATION APPOINTS THOMAS P. MULLIN AS CHIEF EXECUTIVE OFFICER AND ANNOUNCES OTHER CHANGES INVOLVING LONG-TENURED LEADERS

RBC Capital Maintains Outperform on Select Medical Hldgs, Lowers Price Target to $19

Select Medical Hldgs Affirms FY2025 GAAP EPS Guidance of $1.09-$1.19 vs $1.42 Est; Lowers FY2025 Sales Guidance from $5.40B-$5.60B to $5.30B-$5.50B vs $5.47B Est

Select Medical Hldgs Q1 Adj. EPS $0.44 Misses $0.45 Estimate, Sales $1.69B Beat $1.39B Estimate

Examining the Future: Select Medical Hldgs's Earnings Outlook

RBC Capital Maintains Outperform on Select Medical Hldgs, Lowers Price Target to $23

Select Medical Hldgs Q4 Adj $0.18 Misses $0.22 Estimate, Sales $1.31B Miss $1.46B Estimate

Price Over Earnings Overview: Select Medical Hldgs

Reported Earlier, Select Medical Announces Pricing of $550M 6.250% Senior Notes Due 2032

Select Medical Holdings Corporation Declares Special Stock Distribution To Spin-Off Concentra; Estimates Stockholders Will Receive Approximately 0.806971 Shares Of Concentra's Common Stock For Every Share Of Select Medical's Common Stock Held As Of The Cl

Peering Into Select Medical Hldgs's Recent Short Interest

RBC Capital Maintains Outperform on Select Medical Hldgs, Raises Price Target to $47

Benchmark Reiterates Buy on Select Medical Hldgs, Maintains $48 Price Target

Benchmark Reiterates Buy on Select Medical Hldgs, Maintains $48 Price Target

Select Medical Hldgs Raises FY2024 Adj EPS Guidance from $1.96-2.20 to $2.09-2.20 vs $1.86 Est; Raises FY2024 Sales Guidance from $6.90B-7.10B to $6.95B-7.15B vs $7.03B Est

Select Medical Hldgs Q3 2024 Adj. EPS $0.50 Beats $0.43 Estimate, Sales $1.761B Beat $1.737B Estimate